These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28918838)

  • 1. Inhibition of Midkine Suppresses Prostate Cancer CD133
    Erdogan S; Doganlar ZB; Doganlar O; Turkekul K; Serttas R
    Am J Med Sci; 2017 Sep; 354(3):299-309. PubMed ID: 28918838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer.
    Hao H; Maeda Y; Fukazawa T; Yamatsuji T; Takaoka M; Bao XH; Matsuoka J; Okui T; Shimo T; Takigawa N; Tomono Y; Nakajima M; Fink-Baldauf IM; Nelson S; Seibel W; Papoian R; Whitsett JA; Naomoto Y
    PLoS One; 2013; 8(8):e71093. PubMed ID: 23976985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
    Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
    Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells.
    Li K; Liu C; Zhou B; Bi L; Huang H; Lin T; Xu K
    Int J Mol Sci; 2013 Jun; 14(6):11981-93. PubMed ID: 23739676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
    Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B
    Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response.
    Yan J; Tang D
    Exp Cell Res; 2014 Oct; 328(1):132-142. PubMed ID: 25149681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural flavonoid apigenin sensitizes human CD44
    Erdogan S; Turkekul K; Serttas R; Erdogan Z
    Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midkine positively regulates the proliferation of human gastric cancer cells.
    Xu Y; Qu X; Zhang X; Luo Y; Zhang Y; Luo Y; Hou K; Liu Y
    Cancer Lett; 2009 Jul; 279(2):137-44. PubMed ID: 19250738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.
    Zhang Y; Jin Z; Zhou H; Ou X; Xu Y; Li H; Liu C; Li B
    Cancer Med; 2016 Jun; 5(6):1251-8. PubMed ID: 26899963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eupatilin Inhibits the Proliferation and Migration of Prostate Cancer Cells through Modulation of PTEN and NF-κB Signaling.
    Serttas R; Koroglu C; Erdogan S
    Anticancer Agents Med Chem; 2021; 21(3):372-382. PubMed ID: 32781972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
    Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
    Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from
    Kamalidehghan B; Ghafouri-Fard S; Motevaseli E; Ahmadipour F
    Drug Des Devel Ther; 2018; 12():1119-1133. PubMed ID: 29765202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells.
    Mahajan NP; Coppola D; Kim J; Lawrence HR; Lawrence NJ; Mahajan K
    Sci Rep; 2018 Jan; 8(1):1954. PubMed ID: 29386546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor.
    Ishida N; Fukazawa T; Maeda Y; Yamatsuji T; Kato K; Matsumoto K; Shimo T; Takigawa N; Whitsett JA; Naomoto Y
    Exp Cell Res; 2015 Jul; 335(2):197-206. PubMed ID: 25839409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
    El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
    PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer.
    Shin DH; Jo JY; Kim SH; Choi M; Han C; Choi BK; Kim SS
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.